Adalimumab-induced pityriasis rosea

J Eur Acad Dermatol Venereol. 2007 Oct;21(9):1294-6. doi: 10.1111/j.1468-3083.2007.02197.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • Arthritis, Rheumatoid / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Pityriasis Rosea / chemically induced*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Adalimumab